Theranos Investor Conference Presentation Deck

Lipid Panel: Capillary Bias Summary Capillary miniLab vs Venous miniLab Analyte R² Total Cholesterol (mg/dL) 0.98 HDL Cholesterol (mg/dL) 0.96 LDL Cholesterol (mg/dL) 0.97 Triglycerides (mg/dL) 1.00 Median Bias 0.6% 1.9% 0.6% 3.7% Passing-Bablok regression This technology has not been cleared or approved by the FDA and is not for sale in the United States. Capillary miniLab vs Venous ADVIA R² 0.98 0.96 0.95 1.00 Median Bias -0.5% 11.6% 1.4% 5.5% theranos 68

View entire presentation